Please use this identifier to cite or link to this item:
|Title:||Discovery of the first potent and selective Mycobacterium tuberculosis Zmp1 inhibitor.||Authors:||Mori, Mattia
|Issue Date:||2014||Project:||None||Journal:||BIOORGANIC & MEDICINAL CHEMISTRY LETTERS||Abstract:||
The Mycobacterium tuberculosis extracellular zinc metalloprotease 1 (Zmp1) has been proposed to play a key role in phagosome maturation and to enhance the survival of Mycobacterium tuberculosis in the host. Consequently, small molecule inhibitors of Zmp1 are of pivotal importance as a tool to better understand the pathogenicity of Zmp1 and as lead candidates for pharmacological intervention. Here we combined in silico structure-based inhibitor design with biochemical studies to discover and characterize the first potent competitive Zmp1 inhibitor showing a Ki of 94nM and a high selectivity for Zmp1 with respect to human Neprilysin.
|Appears in Collections:||Publications|
Show full item record
checked on May 17, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.